Week 7 Final Exam: NR546 / NR-546
(Latest Update )
Advanced Pharmacology
Psychopharmacology for the
Psychiatric-Mental Health Nurse
Practitioner | Questions and
Answers | 100% Correct | Grade A -
Chamberlain
Question:
Norepinephrine Dopamine Reuptake Inhibitor
bupropion (Wellbutrin)
Answer:
off-label use for ADHD in adults
appropriate for clients with concurrent depression or tobacco abuse
, Question:
Prescribing Pearls: Non-stimulants
Answer:
no potential for abuse or diversion.
effective for the long-term treatment of comorbid anxiety, depression, or
substance abuse.
Selection is based on therapeutic and adverse effects.
special attention to cardiovascular, hepatic, neurological, and renal findings.
Use when clients are too young for stimulants but need medication,
intolerant of or have contraindications for stimulants have a client history of
dependency or drug abuse or lack of response to stimulants alone.
Monitor for abrupt behavior changes, suicidal ideation or self-harm,
aggression, seizures, prolonged QT interval, increased peripheral vascular
resistance, heart rate, and blood pressure.
Concurrent use is contraindicated with MAO inhibitors (within the past 14
days), glaucoma, a history of pheochromocytoma, and cardiac or vascular
disorders.
Non-stimulant medications may exacerbate depression in clients with a
history of the disorder.
Non-stimulant medications can take longer to achieve desired effects than
stimulants.
Withdrawal needs to be tapered to prevent rebound hypertension and
neurological side effects.
increase GABA's inhibitory activity, leading to the decreased output of
excitatory neurotransmitters resulting in the adverse effects related to BZO
use.
(Latest Update )
Advanced Pharmacology
Psychopharmacology for the
Psychiatric-Mental Health Nurse
Practitioner | Questions and
Answers | 100% Correct | Grade A -
Chamberlain
Question:
Norepinephrine Dopamine Reuptake Inhibitor
bupropion (Wellbutrin)
Answer:
off-label use for ADHD in adults
appropriate for clients with concurrent depression or tobacco abuse
, Question:
Prescribing Pearls: Non-stimulants
Answer:
no potential for abuse or diversion.
effective for the long-term treatment of comorbid anxiety, depression, or
substance abuse.
Selection is based on therapeutic and adverse effects.
special attention to cardiovascular, hepatic, neurological, and renal findings.
Use when clients are too young for stimulants but need medication,
intolerant of or have contraindications for stimulants have a client history of
dependency or drug abuse or lack of response to stimulants alone.
Monitor for abrupt behavior changes, suicidal ideation or self-harm,
aggression, seizures, prolonged QT interval, increased peripheral vascular
resistance, heart rate, and blood pressure.
Concurrent use is contraindicated with MAO inhibitors (within the past 14
days), glaucoma, a history of pheochromocytoma, and cardiac or vascular
disorders.
Non-stimulant medications may exacerbate depression in clients with a
history of the disorder.
Non-stimulant medications can take longer to achieve desired effects than
stimulants.
Withdrawal needs to be tapered to prevent rebound hypertension and
neurological side effects.
increase GABA's inhibitory activity, leading to the decreased output of
excitatory neurotransmitters resulting in the adverse effects related to BZO
use.
